Canntab Therapeutics Stock Price, News & Analysis
CTABF
OTC
Company Description
Canntab Therapeutics Ltd (CTABF) is a pharmaceutical company based in Toronto, Ontario, specializing in the research and development of cannabis-based medicine. The company focuses on the production of precise dose formulations to optimize patient outcomes. With a commitment to innovation and quality, Canntab is at the forefront of the medical cannabis industry, aiming to provide effective and reliable products for patients worldwide.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$147.0K
Market Cap
38.9M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Canntab Therapeutics.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the market cap of Canntab Therapeutics (CTABF)?
The market cap of Canntab Therapeutics (CTABF) is approximately 147.0K.
What is Canntab Therapeutics Ltd?
Canntab Therapeutics Ltd is a pharmaceutical company specializing in the research and development of cannabis-based medicine.
Where is Canntab Therapeutics Ltd based?
Canntab Therapeutics Ltd is based in Toronto, Ontario.
What is the focus of Canntab Therapeutics Ltd?
Canntab Therapeutics Ltd focuses on the production of precise dose formulations to optimize patient outcomes.
What is Canntab Therapeutics Ltd's commitment?
Canntab Therapeutics Ltd is committed to innovation and quality in the medical cannabis industry.
What are Canntab Therapeutics Ltd's goals?
Canntab Therapeutics Ltd aims to provide effective and reliable cannabis-based products for patients worldwide.